SCHEMBL21477592

SCHEMBL21477592

CC(C)c1cc2nnsc2nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21477589 0.71 ALDH1A1 (0.32)
SCHEMBL19131857 0.71 PDE2A (0.30)
SCHEMBL21481142 0.69 KCNH2 (0.30)
SCHEMBL21477617 0.69 THRB (0.35)
SCHEMBL22725528 0.68
SCHEMBL22725529 0.67 XPO1 (0.32)
SCHEMBL19287872 0.65 THRB (0.32)
SCHEMBL18237422 0.63
SCHEMBL21481137 0.62
SCHEMBL19130939 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3838897-A2 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY Shenzhen TargetRx, Inc. (CN) 2021-06-23 EP disclosed
EP-3553056-A1 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY Shenzhen Targetrx, Inc. (CN) 2019-10-16 EP disclosed